Devabhaktuni Subodh R, Shirazi Jonathan T, Miller John M
Indiana University, Indianapolis, IN, USA.
Indiana University, Indianapolis, IN, USA.
Card Electrophysiol Clin. 2019 Dec;11(4):689-697. doi: 10.1016/j.ccep.2019.07.001. Epub 2019 Oct 3.
Ventricular arrhythmias (VA) constitute well-known problems in patients with left ventricular assist devices (LVADs), with incidence ranging from 18% to as high as 52%. Catheter ablation has become a common therapeutic intervention to treat drug-refractory VA, particularly with the increase and more widespread use of durable LVADs to bridge patients to transplantation or as destination therapy. In this article, we focus on etiology, mechanisms, periprocedural management, and mapping and ablation techniques in patients with LVADs and VA.
室性心律失常(VA)是左心室辅助装置(LVAD)患者中众所周知的问题,其发生率从18%到高达52%不等。导管消融已成为治疗药物难治性VA的常见治疗干预手段,特别是随着耐用LVAD越来越多地用于将患者过渡到移植或作为终末期治疗。在本文中,我们重点关注LVAD和VA患者的病因、机制、围手术期管理以及标测和消融技术。